Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › BioMérieux, Sysmex Dissolve Japanese Joint Venture

BioMérieux, Sysmex Dissolve Japanese Joint Venture

Jul 27, 2017
|
staff reporter

NEW YORK (GenomeWeb) – BioMérieux and Sysmex announced today that they will dissolve a nearly 10-year-old joint venture that aimed to bring BioMérieux's in vitro diagnostic products to the Japanese market.

No reason was given for the dissolution.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Molecular Diagnostics

  1. BioReference Settles False Claims, Kickback Allegations for $11.5M

  2. United Airlines Launches COVID-19 Testing Program for Travelers to Hawaii

  3. UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

  4. Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

  5. FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.